Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 2003

View Archived Issues

New glucose-lowering agents covered by BMS patent

Merck KGaA presents new agents able to inhibit PDE4 and TNF-alpha production

New factor Xa and/or factor VIIa inhibitors under study at Merck KGaA

Rigel researchers present novel anti-HCV agents

Agents for iron overload therapy disclosed by Novartis researchers

Enanta develops new macrolides

Novel antiangiogenic combretastatin analogues with utility in cancer therapy

Celsion treats first patient in Thermodox trial for prostate cancer

Milnacipran has distinct mechanisms for effects on pain and mood

Prefilled Avonex syringe approved

Lescol and Lescol XL approved for new indication

Corixa and GSK enter Bexxar agreement for Canada

Asimadoline reduces pain threshold associated with colon distension in IBS

Improved hemodynamics reported with sitaxsentan in pulmonary hypertension

SR-140333B effective and well tolerated in ulcerative colitis

Good efficacy and cardiovascular safety profile reported for cilomilast in COPD

Pregabalin improves anxiety scores and work productivity in GAD

Inflazyme acquisition of GlycoDesign approved

Amgen and Tularik form oncology collaboration

Allos updates operating plan for 2003

Cardiome plans phase III for RSD-1235

Pharma Mar advances kahalalide F into phase II for liver carcinoma

Levaquin approved for treatment of chronic bacterial prostatitis

Orally active, small-molecule CXCR3 antagonist represents a new class of transplant therapeutics

NC-1153: a novel immunosuppressant that selectively targets Jak3

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...